Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3040% below fair value
$2.86−0.14 (-4.67%)
Close on Nov 13, 2026Market cap $122.83MP/E –Yield –
Pulmonx enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pulmonx's enterprise value was $109.67M on Nov 11, 2026, against $27.40M a year earlier. Over the last 5 years it ranged from $20.69M to $981.54M, with a median of $242.05M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $109.67M | +112.0% |
| 2025 | Dec 31, 2025 | $51.74M | -78.6% |
| 2024 | Dec 31, 2024 | $242.05M | -43.8% |
| 2023 | Dec 29, 2023 | $430.64M | +144.9% |
| 2022 | Dec 30, 2022 | $175.83M | -82.1% |
| 2021 | Dec 31, 2021 | $981.54M | +340.9% |
| 2020 | Dec 31, 2020 | $222.60M | – |
See a number that looks wrong?